Avoro Capital Advisors LLC Relay Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

  • $6.65 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$13.31 - $34.88 $5.32 Million - $14 Million
400,000 New
400,000 $6.7 Million
Q2 2021

Aug 16, 2021
SELL
$27.5 - $38.19 $13.8 Million - $19.1 Million
-500,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$32.81 - $45.1 $16.4 Million - $22.6 Million
500,000 New
500,000 $21.3 Million

Others Institutions Holding RLAY

# of Institutions
204
Shares Held
156M
Call Options Held
207K
Put Options Held
40K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $537M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email